Davide Sartini

Ancona, 60126, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Xenobiotic Sulforaphane in Head and Neck Cancer: Beyond the Nrf2 Pathway.

Xenobiotic Sulforaphane in Head and Neck Cancer: Beyond the Nrf2 Pathway.

Journal: Journal of xenobiotics

Published: April 15, 2026

Short and Long Non-Coding RNAs in Renal Cell Carcinoma.

Short and Long Non-Coding RNAs in Renal Cell Carcinoma.

Journal: Non-coding RNA

Published: January 24, 2026

Upregulation of paraoxonase-2 enzyme in human osteosarcoma and its involvement in mechanisms promoting the aggressive behavior of tumor cells.

Upregulation of paraoxonase-2 enzyme in human osteosarcoma and its involvement in mechanisms promoting the aggressive behavior of tumor cells.

Journal: Molecular biology reports

Published: January 24, 2026

Cisplatin as a Xenobiotic Agent: Molecular Mechanisms of Actions and Clinical Applications in Oncology.

Cisplatin as a Xenobiotic Agent: Molecular Mechanisms of Actions and Clinical Applications in Oncology.

Journal: Journal of xenobiotics

Published: November 10, 2025

Small Molecule Inhibitors of Nicotinamide N-Methyltransferase Enzyme for the Treatment of Osteosarcoma and Merkel Cell Carcinoma: Potential for the Development of a Targeted Therapeutic Strategy.

Small Molecule Inhibitors of Nicotinamide N-Methyltransferase Enzyme for the Treatment of Osteosarcoma and Merkel Cell Carcinoma: Potential for the Development of a Targeted Therapeutic Strategy.

Journal: Biomolecules

Published: July 10, 2025

NNMT expression in preeclampsia: Analyses on placental tissues and cell lines.

NNMT expression in preeclampsia: Analyses on placental tissues and cell lines.

Journal: Placenta

Published: October 08, 2024

Deepening Cisplatin sensitivity on Oral Squamous cell Carcinoma cell lines after PON2 knockdown: A FTIRM investigation.

Deepening Cisplatin sensitivity on Oral Squamous cell Carcinoma cell lines after PON2 knockdown: A FTIRM investigation.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Published: April 24, 2024

Paraoxonase-2 shRNA-mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines.

Paraoxonase-2 shRNA-mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines.

Journal: Journal of cellular biochemistry

Published: December 23, 2023

Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential.

Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential.

Journal: Anti-cancer agents in medicinal chemistry

Published: December 14, 2023

Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes.

Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes.

Journal: Biomolecules

Published: December 08, 2023

Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration, and chemoresistance of Merkel cell carcinoma cells in vitro.

Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration, and chemoresistance of Merkel cell carcinoma cells in vitro.

Journal: Human cell

Published: December 01, 2023

Enzymes Dysregulation in Cancer: From Diagnosis to Therapeutical Approaches.

Enzymes Dysregulation in Cancer: From Diagnosis to Therapeutical Approaches.

Journal: International journal of molecular sciences

Published: September 05, 2023

Showing 1-12 of 75

Last Updated: 09/26/2026